⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Boric Acid SCHEMBL8755195 | 1.00 | LMNA (0.50) | — | |
| Boric Acid SCHEMBL10338315 | 1.00 | LMNA (0.50) | — | |
| Boric Acid SCHEMBL717521 | 1.00 | LMNA (0.50) | — | |
| Boric Acid SCHEMBL7952456 | 1.00 | LMNA (0.50) | — | |
| Boric Acid SCHEMBL8755210 | 1.00 | LMNA (0.50) | — | |
| Boric Acid SCHEMBL8754803 | 1.00 | LMNA (0.50) | — | |
| Boric Acid SCHEMBL28793742 | 0.94 | LMNA (0.44) | — | |
| Trimethylammonium SCHEMBL17819099 | 0.85 | LMNA (0.36) | — | |
| Dimethylamine SCHEMBL28552842 | 0.75 | — | — | |
| Boric Acid SCHEMBL9188357 | 0.72 | LMNA (0.67) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12508298-B2 | Protein complex by use of a specific site of an immunoglobulin fragment for linkage | HANMI PHARM. CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| US-20250197466-A1 | METHODS OF TREATMENT USING G-CSF PROTEIN COMPLEX | ASSERTIO SPECIALTY PHARMACEUTICALS, LLC | 2025-06-19 | — | — | US | claimed |
| EP-4534107-A2 | PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE | Hanmi Pharm. Co., Ltd. (KR) | 2025-04-09 | — | — | EP | claimed |
| CN-115109277-B | Conductive microsphere with surface protrusion structure and preparation method and application thereof | 苏州鑫导电子科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119491213-A | Microsphere surface chemical nickel plating method based on double reduction system | 安徽中科元贞科技有限责任公司 | 2025-02-21 | — | — | CN | claimed |
| CN-118459643-A | Core-shell structure polymer conductive microsphere and preparation method thereof | 浙江福莱新材料股份有限公司 | 2024-08-09 | — | — | CN | claimed |
| EP-3689942-B1 | PROTEIN COMPLEX COMPRISING NON-PEPTIDYL POLYMER-COUPLED FATTY ACID DERIVATIVE COMPOUND AS LINKER AND PREPARATION METHOD THEREFOR | HANMI PHARMACEUTICAL CO LTD (KR) | 2024-06-19 | — | — | EP | claimed |
| CN-117603470-A | Core-shell structure polymer silicon dioxide-based conductive microsphere and preparation method thereof | 浙江福莱新材料股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-114457325-B | Nickel layer thickness control method for nickel-plated high polymer microspheres | 安徽中科元贞科技有限责任公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116770280-A | Preparation method of nickel-plated microsphere with controllable surface roughness | 安徽中科元贞科技有限责任公司 | 2023-09-19 | — | — | CN | claimed |
| WO-2004083242-A1 | HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR CONJUGATE HAVING ENHANCED STABILITY IN BLOOD AND PROCESS FOR THE PREPARATION THEREOF | HANMI PHARM. CO. LTD. (KR) | 2004-09-30 | — | — | WO | claimed |
| WO-2004081053-A1 | PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE | HANMI PHARM. CO. LTD. (KR) | 2004-09-23 | — | — | WO | claimed |
| US-20040181035-A1 | Modified colony stimulating factor for treatment of hematopoietic disorder | AMGEN, INC. | 2004-09-16 | — | — | US | claimed |
| US-20040180054-A1 | Physiologically active polypeptide conjugate having prolonged in vivo half-life | HANMI PHARM. CO., LTD. | 2004-09-16 | — | — | US | claimed |
| US-20030096400-A1 | N-terminally chemically modified protein compositions and methods | AMGEN, INC. | 2003-05-22 | — | — | US | claimed |
| US-20030053982-A1 | N-terminally chemically modified protein compositions and methods | KINSTLER OLAF B (US) | 2003-03-20 | — | — | US | claimed |
| US-6265309-B1 | Cleaning agent for use in producing semiconductor devices and process for producing semiconductor devices using the same | MITSUBISHI GAS CHEMICALS CO., INC. (JP) | 2001-07-24 | — | — | US | claimed |
| JP-3177251-B2 | — | — | 2001-06-18 | — | — | JP | claimed |
| EP-0733067-A1 | N-TERMINALLY CHEMICALLY MODIFIED PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 1996-09-25 | — | — | EP | claimed |
| WO-1996011953-A1 | N-TERMINALLY CHEMICALLY MODIFIED PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 1996-04-25 | — | — | WO | claimed |